Identifying and Diagnosing EoE

Identifying patients who should be further evaluated for eosinophilic esophagitis (EoE) can be challenging. Some individuals have a higher risk of EoE based on family history and ancestry, male sex, and comorbid atopic disease.1,2

Evidence is accumulating that environmental factors, premature or cesarean birth, early antibiotic exposure, food allergy, lack of breast feeding, and lack of early microbial exposure are also linked to development of EoE.2 

Table 1: Identifying and Diagnosing EoE3

Clinical manifestations of EoE, which are largely attributed to esophageal dysfunction from epithelial remodeling, can be non-specific and may vary depending on several factors, including endotype, duration of disease, and patient age.4 Symptoms in pediatric patients include nausea, vomiting and abdominal pain, while adolescents and adults are more likely to present with dysphagia, heartburn, food impaction, and regurgitation (Table 1).5

EoE reference score, EREFS representing Edema, Rings, Exudate, Furrows and Stricture is used for endoscopic findings. Patients suspected of having EoE undergo esophagogastroduodenoscopy (EGD) to assess the extent of eosinophilic infiltration. Diagnostic criteria and other conditions with associated esophageal eosinophilia are listed in Table 1. Patients who have ≥15 eosinophils/high-powered field should be evaluated for EoE.6 EoE is patchy – at least 6 biopsies are needed at 2 esophageal levels in any patient with dysphagia.3 Of note, failure of a trial of proton pump inhibitors (PPI) is no longer part of the diagnostic criteria for EoE. Differentiating between EoE and GERD can be particularly challenging due to the similarity in their clinical signs.

Figure 1 EoE Diagnostic Algorithm3

References

  1. Khan S, Guo X, Liu R, et al. An update on eosinophilic esophagitis: Etiological factors, coexisting diseases, and complications. Digestion. 2021;102:342-356. doi:10.1159/000508191
  2. Lyles J, Rothenberg M. Role of genetics, environment, and their interactions in the pathogenesis of eosinophilic esophagitis. Curr Opin Immunol. 2019;60:46-53. doi:10.1016/j.coi.2019.04.004
  3. Dellon, ES et al. ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis. Am J Gastroenterol. 2025;120:31-59.
  4. Chen JW. Management of eosinophilic esophagitis: Dietary and nondietary approaches. Nutr Clin Pract. 2020;35(5):835-847. doi:10.1002/ncp.10571
  5. Muir A, Falk GW. Eosinophilic esophagitis: A review. JAMA. 2021;326(13):1310-1318. doi:10.1001/jama.2021.14920
  6. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterol. 2018;155(4):1022-1033.e10. doi:10.1053/j.gastro.2018.07.009
Directory

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Directory

Search

[divi_global_search_form]

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

[patient_toolkit]
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner